Common name
4-methoxybenzamide
IUPAC name
4-methoxybenzamide
SMILES
O=C(N)c1ccc(cc1)OC
Common name
4-methoxybenzamide
IUPAC name
4-methoxybenzamide
SMILES
O=C(N)c1ccc(cc1)OC
INCHI
InChI=1S/C8H9NO2/c1-11-7-4-2-6(3-5-7)8(9)10/h2-5H,1H3,(H2,9,10)
FORMULA
C8H9NO2
Common name
4-methoxybenzamide
IUPAC name
4-methoxybenzamide
Molecular weight
151.163
clogP
0.967
clogS
-1.491
Frequency
0.0014
HBond Acceptor
2
HBond Donor
2
Total PolarSurface Area
52.32
Number of Rings
1
Rotatable Bond
2
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00527 | Trimethobenzamide |
|
Antiemetics; Respiratory System; Aminoalkyl Ethers; Antihistamines for Systemic Use; | For the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis. |
| FDBD01073 | Encainide |
|
Anti-Arrhythmia Agents; Voltage-Gated Sodium Channel Blockers; Sodium Channel Blockers; Cardiovascular System; Antiarrhythmics, Class I and Iii; Cardiac Therapy; Antiarrythmics, Class I and Iii; Antiarrhythmics, Class Ic; CYP2D6 Inducers; CYP2D6 Inducers (strong); | Encainide is a class Ic antiarrhythmic agent which was used for management of irregular heartbeats, such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. |
| FDBD01187 | Pranlukast |
|
Anti-Asthmatic Agents; Respiratory System; Drugs for Obstructive Airway Diseases; Leukotriene Receptor Antagonists; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; CYP3A4 Inhibitors; | Used as an adjunct to the standard therapy of inhaled steroids with inhaled long- and/or short-acting beta-agonists. |
| FDBD02388 | etobenzanid |
|
Herbicide | Herbicide |
4 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 1xon_ligand_2_4.mol2 | 1xon | 1 | -6.83 | NC(=O)c1ccc(cc1)OC | 11 |
| 1xm4_ligand_2_4.mol2 | 1xm4 | 1 | -6.82 | NC(=O)c1ccc(cc1)OC | 11 |
| 4gj7_ligand_2_5.mol2 | 4gj7 | 1 | -6.45 | c1(ccc(cc1)OC)C(=O)N | 11 |
| 4rz1_ligand_2_12.mol2 | 4rz1 | 1 | -6.43 | O(C)c1ccc(C(=O)N)cc1 | 11 |
| 4ryg_ligand_2_4.mol2 | 4ryg | 1 | -6.42 | c1(ccc(cc1)C(=O)N)OC | 11 |
| 4ryc_ligand_2_1.mol2 | 4ryc | 1 | -6.41 | c1c(ccc(c1)C(=O)N)OC | 11 |
| 4jvq_ligand_2_27.mol2 | 4jvq | 1 | -6.25 | c1(ccc(cc1)OC)C(=O)N | 11 |
| 4wx4_ligand_2_8.mol2 | 4wx4 | 1 | -6.07 | c1(ccc(cc1)C(=O)N)OC | 11 |
| 1lf3_ligand_3_798.mol2 | 1lf3 | 1 | -5.92 | O(C)c1ccc(C(=O)N)cc1 | 11 |
| 4jmu_ligand_2_27.mol2 | 4jmu | 1 | -5.87 | O(C)c1ccc(C(=O)N)cc1 | 11 |
103 ,
11
